DFX Intelligence
Borrowers
1,055 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,055 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| SimonMed, Inc Healthcare services | Sponsor not establishedpossible: American Securities LLC (a company of this name is on the sponsor's portfolio page) | 4 | at least $342M | 100c | 0 pts | Feb 1, 2031 | Mar 31, 2025 |
| Covetrus, Inc Life sciences | Clayton, Dubilier & Rice, LLC inferred | 13 | at least $338M | 101c | 3 pts | Oct 1, 2029 | Sep 30, 2022 |
| Patriot Acquisition Topco S.A.R.L Life sciences | unattributed | 6 | at least $337M | 100c | 1 pts | Jan 1, 2028 | Dec 31, 2021 |
| C•••• G•••••• I•• Life sciences | unattributed | 8 | at least $326M | 60c | n/a | Dec 6, 2029 | Dec 31, 2021 |
| D•• C••••••••• H••••••• P•• L•• • Life sciences | unattributed | 1 | at least $318M | 105c | n/a | Oct 29, 2032 | Sep 30, 2025 |
| O•• C••• M•••••• O•• C••• C••••••••• Healthcare services | unattributed | 1 | at least $309M | 100c | n/a | Sep 10, 2030 | Sep 30, 2025 |
| S•••• M••••••••• B••••• I•• Healthcare services | unattributed | 7 | at least $308M | 99c | 1 pts | May 29, 2030 | Dec 31, 2022 |
| A••••• B•••••• S•••••• I••••••••• L•• Life sciences | unattributed | 13 | at least $297M | 100c | 1 pts | Oct 1, 2030 | Dec 31, 2022 |
| T•••• I•• Life sciences | A•••••••• C•••••• P••••••• inferred | 7 | at least $294M | 100c | 1 pts | Nov 1, 2030 | Dec 31, 2023 |
| A••••••• P••••••• M••••••••• I•• Education | Sponsor not establishedpossible: A•• Q• A••••••• L•• (a company of this name is on the sponsor's portfolio page) | 12 | at least $285M | 82c | 1 pts | Feb 1, 2028 | Sep 30, 2022 |
| S••••••• S••••• H••••••••• S•••••••• L•• Healthcare services | unattributed | 11 | at least $279M | 100c | 0 pts | Jan 5, 2028 | Dec 31, 2021 |
| O• H••••••••• G••••• I•• Life sciences | Sponsor not establishedpossible: K••••••• • C•••••• (a company of this name is on the sponsor's portfolio page) | 16 | at least $277M | 101c | 1 pts | Jan 1, 2031 | Dec 31, 2021 |
| A•• T••••• L•• Healthcare services | Sponsor not establishedpossible: B•••••• P•••• C•••••• A•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 19 | at least $273M | 100c | 2 pts | Mar 1, 2027 | Dec 31, 2021 |
| S•••• H•••••••• I•• Healthcare services | unattributed | 5 | at least $262M | 100c | 0 pts | Feb 1, 2032 | Mar 31, 2025 |
| M•••• N• I•• Life sciences | unattributed | 16 | at least $262M | 100c | 1 pts | May 13, 2031 | Jun 30, 2024 |
| A•••• A• F•••• P•• L•• Life sciences | unattributed | 3 | at least $258M | 97c | n/a | May 27, 2033 | Mar 31, 2026 |
| T••••••• H•••••••• I•• Life sciences | unattributed | 7 | at least $258M | 101c | 1 pts | May 12, 2032 | Dec 31, 2021 |
| F••••• P••••• H•••••••• I•• Life sciences | unattributed | 6 | at least $257M | 98c | n/a | Nov 6, 2031 | Dec 31, 2024 |
| O•••• H•••••• B•• Healthcare services · grade B | unattributed | 1 | at least $248M | 98c | n/a | Oct 21, 2032 | Mar 31, 2026 |
| N•••••• P•••••••• L•• Life sciences | unattributed | 8 | at least $248M | 101c | 1 pts | Nov 1, 2030 | Dec 31, 2021 |
| O•••• H••••••••• O••••••••• H•••••••• I•• Healthcare services | unattributed | 2 | at least $248M | 97c | n/a | Apr 1, 2030 | Dec 31, 2023 |
| N••• H•••••• L•• Healthcare services | unattributed | 18 | at least $246M | 100c | 2 pts | Nov 1, 2029 | Dec 31, 2022 |
| P•••••• R••• U••••••• P••••• C••• Healthcare services | unattributed | 20 | at least $240M | 100c | 0 pts | Mar 1, 2028 | Dec 31, 2021 |
| I•••••• 3••• L•• Healthcare services | unattributed | 15 | at least $238M | 100c | 2 pts | Nov 15, 2027 | Sep 30, 2022 |
| M••••••• C••••••••• Life sciences | unattributed | 3 | at least $228M | 99c | n/a | Aug 6, 2030 | Mar 31, 2022 |
| G••• B•••• I•• Life sciences | unattributed | 3 | at least $216M | 101c | 2 pts | Oct 1, 2031 | Dec 31, 2024 |
| S••••• S•••••••• I•• Healthcare services | unattributed | 15 | at least $213M | 68c | 19 pts | Dec 1, 2027 | Dec 31, 2021 |
| C•••••• P••••• I•• Life sciences | unattributed | 8 | at least $213M | 100c | 2 pts | Sep 1, 2030 | Sep 30, 2025 |
| H••••••• S••••••• S•••••••• L•• Healthcare services | unattributed | 5 | at least $208M | 99c | 0 pts | Jun 16, 2031 | Jun 30, 2024 |
| K••••• I••••••••• A• Life sciences | unattributed | 1 | at least $206M | 99c | n/a | Apr 22, 2032 | Sep 30, 2024 |
| S••• P••••••••• I•• Healthcare services | unattributed | 7 | at least $205M | 100c | 3 pts | Jun 30, 2032 | Dec 31, 2025 |
| O••• B•••••••• L•• Life sciences | unattributed | 13 | at least $205M | 100c | 2 pts | Apr 26, 2029 | Dec 31, 2021 |
| C•••••••• I•• Healthcare services | Sponsor not establishedpossible: V•••••• C•••••• F••• M••••••••• L••••• (a company of this name is on the sponsor's portfolio page) | 23 | at least $202M | 93c | 3 pts | Feb 24, 2031 | Mar 31, 2024 |
| D••••••• C• T••••••••• I••••••••• H••••••• Healthcare services | unattributed | 1 | at least $200M | 98c | n/a | Aug 30, 2031 | Sep 30, 2025 |
| C••••••• C•••• P•••••• I•• Life sciences | unattributed | 1 | at least $200M | 100c | n/a | Dec 18, 2031 | Dec 31, 2024 |
| E•••••••• I•• Healthcare services | Sponsor not establishedpossible: W•••••• P••••• L•• (a company of this name is on the sponsor's portfolio page) | 4 | at least $200M | 99c | n/a | Feb 22, 2030 | Dec 31, 2021 |
| N• K••••• B••••• I•• Life sciences | Sponsor not establishedpossible: C••••••• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 7 | at least $198M | 100c | 0 pts | Jan 1, 2033 | Dec 31, 2022 |
| B•••••• Life sciences | unattributed | 12 | at least $196M | 101c | 1 pts | Aug 1, 2028 | Sep 30, 2021 |
| C•••••• L•• Life sciences · grade B | unattributed | 1 | at least $188M | 100c | n/a | Jun 18, 2029 | Jun 30, 2024 |
| B••• R•••• P•• C•••• L•• Healthcare services | unattributed | 13 | at least $188M | 100c | 0 pts | Aug 1, 2029 | Sep 30, 2021 |
| P••••••••• Life sciences | unattributed | 1 | at least $185M | 102c | n/a | Oct 15, 2032 | Dec 31, 2025 |
| M••••••• H•••••• L•• Healthcare services | unattributed | 1 | at least $185M | 99c | n/a | Feb 1, 2029 | Mar 31, 2024 |
| A•• H••••• B•• L•• Healthcare services | unattributed | 7 | at least $184M | 99c | 2 pts | Jul 31, 2032 | Dec 31, 2024 |
| M•••••••• L• Healthcare services | Sponsor not establishedpossible: T••• W••• C•••••• M••••••••• L••• (a company of this name is on the sponsor's portfolio page) | 10 | at least $184M | 101c | 1 pts | Sep 30, 2032 | Sep 30, 2025 |
| N•• A•• B•••• L•• Healthcare services | unattributed | 8 | at least $180M | 101c | 0 pts | Jun 1, 2031 | Jun 30, 2026 |
| P••• L•• Life sciences | Sponsor not establishedpossible: G•••••• C•••••• (a company of this name is on the sponsor's portfolio page) | 6 | at least $178M | 100c | n/a | Mar 1, 2028 | Dec 31, 2021 |
| P•••••• P•••••• L•• Healthcare services | unattributed | 3 | at least $177M | 100c | 0 pts | Sep 21, 2032 | Sep 30, 2025 |
| m••••• M•••••• I•• Healthcare services | unattributed | 11 | at least $173M | 97c | 4 pts | Aug 26, 2032 | Dec 31, 2022 |
| H••••••• I•• Life sciences | unattributed | 10 | at least $173M | 99c | 1 pts | Apr 1, 2033 | Sep 30, 2025 |
| P•••••• C•••••• B••••• I•• Healthcare services · grade B | unattributed | 3 | at least $171M | 100c | 0 pts | Apr 1, 2033 | Mar 31, 2022 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.